Document Detail


A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report.
MedLine Citation:
PMID:  3655305     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Colchicine (1 mg/day), or an identical placebo, was given to 64 patients with primary biliary cirrhosis in a double-blind controlled trial. Due to a novel, pair-matched trial design, the two groups were exceptionally well matched at entry. In comparison with placebo, colchicine produced a beneficial effect on serum albumin and bilirubin levels at 3 months in patients who had abnormal liver function (bilirubin greater than 20 mumol/l) at entry: (albumin, P = 0.047; bilirubin, P = 0.022). In patients with normal liver function at entry (bilirubin less than 20 mumol/l), beneficial effects were noted on total globulin levels at 3 months (P = 0.013) and on immunoglobulin G levels at 3 and 6 months (P = 0.044 and 0.001, respectively). At 18 months, survival estimate in the colchicine and placebo groups were 84% and 69%, respectively. The difference did not reach significance. Colchicine produced an early improvement in liver function and immunoglobulin levels. Few serious side effects were encountered, and colchicine clearly merits long-term study in the treatment of primary biliary cirrhosis.
Authors:
T W Warnes; A Smith; F I Lee; N Y Haboubi; P J Johnson; L Hunt
Related Documents :
10580355 - Ultrasonic evaluation of congestive liver after tricuspid annuloplasty.
20371655 - Retrospective observational study on the effects and tolerability of flutamide in a lar...
21157975 - Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleedi...
21294085 - Meta-analyses of intracerebral hematoma treatment.
17745985 - Glaciation about 3,000,000 years ago in the sierra nevada.
21063285 - Evaluation of caudal anesthesia performed in conscious infants for lower abdominal surg...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of hepatology     Volume:  5     ISSN:  0168-8278     ISO Abbreviation:  J. Hepatol.     Publication Date:  1987 Aug 
Date Detail:
Created Date:  1987-11-06     Completed Date:  1987-11-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8503886     Medline TA:  J Hepatol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  1-7     Citation Subset:  IM    
Affiliation:
University Department of Gastroenterology, Manchester Royal Infirmary, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bilirubin / blood
Colchicine / adverse effects,  therapeutic use*
Humans
Immunoglobulins / analysis
Liver Cirrhosis, Biliary / drug therapy*,  immunology,  pathology
Serum Albumin / analysis
Serum Globulins / analysis
Chemical
Reg. No./Substance:
0/Immunoglobulins; 0/Serum Albumin; 0/Serum Globulins; 635-65-4/Bilirubin; 64-86-8/Colchicine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Liver sinusoids and sinusoidal cells in patients with agnogenic myeloid metaplasia.
Next Document:  Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A sa...